S 5237 Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
To require the Director of the National Institute of Allergy and Infectious Diseases to award a competitive grant for the Antibiotic Resistance Leadership Group for the purpose of facilitating a clinical research network on antibiotic resistance, and for other purposes.
Summary
- Requires the Director of the National Institute of Allergy and Infectious Diseases to award a competitive grant for the Antibiotic Resistance Leadership Group.
- Directs the grant to be used to facilitate a clinical research network focused on antibiotic resistance.
- Specifies that the clinical research network shall focus on supporting rapid recruitment of clinical trial participants, conducting recruitment outreach in community settings, pairing diagnostic and pharmaceutical innovations during clinical trials, and developing patient-reported outcomes in clinical studies.
- Authorizes appropriations as necessary to carry out the grant program.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
1 cosponsor
- Sen. Marshall, Roger [R-KS] (R-KS)
Actions (2)
- Aug 4, 2026 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. · senate
- Aug 4, 2026 Introduced in Senate
Text versions (1)
Bills are re-published as they move (Introduced → Reported → Engrossed → Enrolled …). Each stage below is a separate text; pick two to see what changed. Data from Congress.gov.
Full text
IN THE SENATE OF THE UNITED STATES
August 4, 2026
Ms. Hassan (for herself and Mr. Marshall) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions
A BILL
To require the Director of the National Institute of Allergy and Infectious Diseases to award a competitive grant for the Antibiotic Resistance Leadership Group for the purpose of facilitating a clinical research network on antibiotic resistance, and for other purposes.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the “Stop Superbugs Act”.
SEC. 2. FUNDING FOR ANTIBIOTIC RESISTANCE CLINICAL RESEARCH.
(a) In General.—The Director of the National Institute of Allergy and Infectious Diseases shall award a competitive grant for the Antibiotic Resistance Leadership Group for the purpose of facilitating a clinical research network on antibiotic resistance, which shall include focuses on—
(1) supporting rapid recruitment of clinical trial participants;
(2) conducting clinical trial recruitment outreach in community settings;
(3) supporting the pairing of diagnostic and pharmaceutical innovations during clinical trials; and
(4) developing patient-reported outcomes in clinical studies.
(b) Authorization of Appropriations.—There is authorized to be appropriated to the Director of the National Institute of Allergy and Infectious Diseases such sums as may be necessary to carry out subsection (a). <all>
Comments